首页> 外文期刊>Journal of Inorganic Biochemistry: An Interdisciplinary Journal >Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand
【24h】

Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand

机译:具有糖精配体的金(I)/(III)配合物的结构和溶液化学,蛋白质结合和抗增殖特性

获取原文
获取原文并翻译 | 示例
           

摘要

A series of new gold(I) and gold(III) complexes based on the saccharinate (sac) ligand, namely M[Au(sac)2] (with M being Na+, K + or NH4+), [(PTA)Au(sac)], K[Au(sac) 3Cl] and Na[Au(sac)4], were synthesized and characterized, and some aspects of their biological profile investigated. Spectrophotometric analysis revealed that these gold compounds, upon dissolution in aqueous media, at physiological pH, manifest a rather favourable balance between stability and reactivity. Their reactions with the model proteins cytochrome c and lysozyme were monitored by mass spectrometry to predict their likely interactions with protein targets. In the case of disaccharinato gold(I) complexes, cytochrome c adducts bearing four coordinated gold(I) ions were preferentially formed in high yield. In contrast, [(PTA)Au(sac)] (PTA = 1,3,5-triaza-7-phosphaadamantane) turned out to be poorly effective, only producing a mono-metalated adduct in very low amount. In turn, the gold(III) saccharinate derivatives were less reactive than their gold(I) analogues: K[Au(sac)3Cl] and Na[Au(sac)4] caused moderate protein metalation, again with evidence of formation of tetragold adducts. Finally, the above mentioned gold compounds were challenged against the reference human tumor cell line A2780S and its cisplatin resistant subline A2780R and their respective cytotoxic profiles determined. [(PTA)Au(sac)] turned out to be highly cytotoxic whereas moderate cytotoxicities were observed for the gold(III) complexes and only modest activities for disaccharinato gold(I) complexes. The implications of these results are thoroughly discussed in the light of current knowledge on gold based drugs.
机译:一系列基于糖精(sac)配体的新金(I)和金(III)配合物,即M [Au(sac)2](M为Na +,K +或NH4 +),[(PTA)Au( sac)],K [Au(sac)3Cl]和Na [Au(sac)4]进行了合成和表征,并对它们的生物学特性进行了研究。分光光度分析表明,这些金化合物在生理pH下溶于水性介质后,在稳定性和反应性之间表现出相当有利的平衡。通过质谱监测它们与模型蛋白细胞色素c和溶菌酶的反应,以预测它们与蛋白靶标的可能相互作用。在discharcharinato金(I)配合物的情况下,优先以高收率形成带有四个配位的金(I)离子的细胞色素C加合物。相反,[(PTA)Au(sac)](PTA = 1,3,5-triaza-7-phosphaadamantane)效果很差,仅产生非常少量的单金属加合物。反过来,糖精金(III)衍生物的反应性也比其金精(I)类似物低:K [Au(sac)3Cl]和Na [Au(sac)4]引起中等程度的蛋白质金属化,再次证明形成了四金加合物。最后,将上述金化合物攻击参考人肿瘤细胞系A2780S及其顺铂抗性亚系A2780R,并确定其各自的细胞毒特性。结果表明,[(PTA)Au(sac)]具有很高的细胞毒性,而金(III)配合物则具有中等的细胞毒性,而二糖金(I)配合物仅具有适度的活性。根据有关金基药物的最新知识,对这些结果的含义进行了全面讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号